Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Peplin initiates final phase III PEP-005 gel trial in actinic keratoses

July 24, 2009

R-Tech Ueno completes phase I RK-023 study

July 22, 2009

Provectus initiates phase II PH-10 trial with new dosing regimen in psoriasis

July 22, 2009

Seoul National University and AmorePacific present novel SPC modulators

July 21, 2009

Centocor Ortho Biotech begins phase I study of psoriasis treatment CNTO-1959

July 21, 2009

NICE recommends use of Basilea's Toctino for severe chronic hand eczema

July 17, 2009

Capstone completes enrollment in first of two phase II trials of AZX-100 in keloid scarring

July 17, 2009

Clinuvel reports phase II results for afamelanotide in solar urticaria

July 16, 2009

PharmaSurgics completes phase I study of PXL-01 for postsurgical adhesion formation

July 15, 2009

Novel PDE4 inhibitor K-34 shows effectiveness in chronic dermatitis in vivo

July 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...